Navamedic establishes chitin production in Northern Norway
Navamedic will rent facilities adjacent to Nergård Reker, which will supply shrimp shells for the extraction of chitin. This is the starting material for production of glucosamine, an active pharmaceutical ingredient for osteoarthritis symptom treatment. Navamedic's glucosamine product was recently approved for medicinal use in 20 European countries, and the company is currently building a network of marketing and distribution partners across Europe.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.